NCT00156845View on ClinicalTrials.gov

Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

June 30, 2006

Conditions
Coronary Artery Disease
Interventions
PROCEDURE

AI-700 contrast-enhanced echocardiography

Trial Locations (1)

02472

Acusphere, Inc., Watertown

Sponsors

Lead Sponsor

Acusphere
All Listed Sponsors
lead

Acusphere

INDUSTRY

NCT00156845 - Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography | Biotech Hunter | Biotech Hunter